Salipro Biotech is heading to PEGS Europe 2025

Written By Lorena Galan

On November 13, our CEO Jens Frauenfeld will take the stage as an invited speaker sharing our latest data on next-generation CXCR4 antibodies developed with the Salipro® platform, overcoming GPCR antibody discovery challenges.

You can also meet our BD Director, Peter Jahnmatz, at the poster session to learn how the Salipro® platform enables antibody discovery towards complex membrane protein targets.

  • November 11–13 | Lisbon, Portugal.

If you are attending, let’s connect, we’d love to meet!

Find more info here: https://www.pegsummiteurope.com/

Lorena Galan
Next

Salipro Biotech Strengthens Global IP Portfolio with Two New Japanese Patents